Luo Li’s research while affiliated with Fudan University and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (4)


Hybrid Decision Tree and Markov model. Abbreviations: with com-, with comorbidity; FLD, fatty liver disease; CC, compensatory cirrhosis; DC, decompensated cirrhosis; HCC, hepatocellular carcinoma; LT, liver transplantation; CHD, coronary heart disease; MI, myocardial infarction; T2DM, type 2 diabetes mellitus
Tornado Diagram for One-way Sensitivity Analysis. Abbreviations: DJBS, duodenal–jejunal bypass sleeve; ILI, intensive lifestyle intervention; ALD, alcoholic fatty liver disease; FLD, fatty liver disease; T2DM, type 2 diabetes mellitus
The Cost-effectiveness planes and cost-effectiveness acceptability curves. Abbreviations: DJBS, duodenal–jejunal bypass sleeve; ILI, intensive lifestyle intervention
Base case cost-effectiveness results (9 months)
Base case cost-effectiveness results (lifetime)

+1

Cost-effectiveness analysis of duodenal–jejunal bypass sleeve device for people with obesity
  • Article
  • Full-text available

April 2025

·

4 Reads

Health Economics Review

Qian Xu

·

Wei Yan

·

Luo Li

·

Bao Liu

Background Obesity has become major public health problem around the world. Lifestyle interventions, Pharmacotherapy and bariatric surgery are the common intervention to reduce weight in clinical practice. This study aims to conduct an economic evaluation of Duodenal–Jejunal Bypass Sleeve (DJBS) plus Intensive Lifestyle Intervention (ILI) compared with ILI only in people with obesity in China. Methods A hybrid model using a Decision Tree and Markov model was used to compare 9-month and lifetime horizon cost-effectiveness between DJBS plus ILI and ILI only. The data on clinical effectiveness were based on a prospective, open-label, and randomized trial (NCT05938231). This study employed 1–3 times the Gross Domestic Product (GDP) per capita (¥85,498, exchange rate: $1 US dollar = ¥6.73, 2022) and disposable income per capita (¥36,883, 2022) as the Willingness-To-Pay (WTP) thresholds. One-way, probabilistic sensitivity and scenario analysis were performed to test the robustness of the results. Results The results of the 9-month decision tree model showed that compared to ILI only, DJBS plus ILI decreased body mass index (BMI) by 1.69 kg/m2 (1.41 vs. 3.10), with an increasing cost of ¥28,963.98 yuan (¥29,111.06 vs.¥147.08). The incremental cost-effectiveness ratio (ICER) was ¥17,138.45 per unit decrease of BMI. The lifetime horizon model showed that compared to ILI only, DJBS plus ILI had a higher cost of ¥13261.94 yuan (¥31,688.98 vs. ¥18,427.04), while with a life-year increase of 0.02 (9.43 vs. 9.41) and quality-adjusted life years (QALYs) increase of 0.15 (7.82 vs. 7.67) per people with obesity. The ICER was ¥88,412.93 per QALY gained. Probability sensitivity analysis showed the robustness of the economic evaluation results. Conclusion The findings suggested that DJBS plus ILI was not a cost-effective strategy over a lifetime horizon when the WTP threshold was set at GDP per capita and disposable income per capita. However, it was considered cost-effective when the threshold was set at 1.03 times GDP per capita.

Download

The price levels of medical services across 31 provincial regions in China. Notes The price level of Shanghai was 100, based on the GEKS method
Regional price differences of medical services: evidence from China

August 2024

·

15 Reads

BMC Public Health

Background Price levels of medical services may vary across regions with different income levels, which would raise concerns about the equal access to medical services. This study aimed to estimate the spatial price index of medical services to measure price levels across 31 provincial regions in China. Methods Price data were collected from medical service price schedule in each region. Two methods based on the Purchasing Power Parities were used to estimate the spatial price index and measure price differences across regions. The two-way fixed effects models were used to examine the association between medical service price levels and income levels, and further investigate the impacts of price differences on utilization of medical services and medical expenditure. Results The consistent estimation results were given by two methods. Medical service price level in the highest-price region was found to be 74% higher than the lowest. There was a significant negative correlation between price levels and income levels, as well as price levels and the utilization of outpatient services. Moreover, we also found a 1% increase in medical service price level was significantly associated with a 0.34% and 0.24% increase in the medical service expense per outpatient visit and per inpatient respectively. Conclusions Regions in China had significant gaps in medical service price levels. Policymakers should pay more attention to regional price differences and take great measures such as enhancing financial protection to ensure the equal access to medical services and better achieve the universal health coverage.


Time trends of the health expenditure and decomposing factors between 2000 and 2021. a Left y-axis represents THE (total health expenditure), TMSE (total medical service expenditure), and TPE (total pharmaceuticals expenditure). Right y-axis represents GDP (gross domestic product). The units for both y-axes are in 100 billion Chinese RMB. b y-axis refers to percentages. c Left y-axis represents the number of outpatient visits. Right y-axis represents the number of hospital admissions. The units for both y-axes are in 100 million visits. d y-axis refers to the price index, including CPI (consumer price index), HPI (health care price index), MPI (medicine price index), and MSPI (medical service price index)
Assessing the price levels of medical service and influential factors: evidence from China

January 2024

·

22 Reads

·

4 Citations

BMC Public Health

Background Medical service prices play a crucial role in cost containment in China. This study aimed to assess the change in medical service price levels at the macro level and the relationship with relevant macroeconomic factors. Methods Data from the 2022 China Statistics Yearbook, the 2022 China Health Statistics Yearbook, and the 2020 China National Health Accounts Report were used. Time trends of health price levels, utilization, and health expenditure were examined. A time-series regression model was employed to measure the impact of service utilization and medical service prices on total medical service expenditure growth from 2000 to 2021. The Johansen cointegration test was conducted to test the cointegrating relationship between medical service price levels and total medical service expenditure, average wage of employees and CPI. The Granger causality test was performed to observe the direction of causality. Results Descriptive analyses showed consistent growth in utilization and medical service price levels from 2000 to 2021. The time-series model indicated that medical service expenditure was influenced by the rise in inpatient admissions and price levels of medical service and medicine. The Johansen cointegration test identified a long-term equilibrium relationship between medical service price levels and total medical service expenditure, average wage and CPI. The change in medical service price levels was the Granger cause of the change in medical service expenditure, but it had no impact on average wage and CPI. However, the change in medical service price levels was influenced by these three macroeconomic factors. Conclusions The growth of medical service expenditure in China was driven by inpatient use and price level. There was a long-term equilibrium relationship between medical service price levels and relevant macroeconomic factors. However, medical service price levels only affected medical service expenditure and have no impact on average wage and CPI. It is necessary to improve the value transmission mechanism of medical service prices.


The template of medical services price schedule in each region. Note: This was selected from the price schedule of Shanghai and translated into English. The price schedules of the other three provinces in the Yangtze River Delta were similar to this
Changes in the price levels of medical services from 2015 to 2020. Note: Zhejiang province in 2020 = 100, based on GEKS methods
Comparison of medical services price levels and socioeconomic levels. Note: *: Zhejiang province = 100, based on GEKS methods; GDP per capita: Gross Domestic Product per capita, CNY, 2020; Wage: Average Wage of Employed Persons in Urban, CNY, 2020; Income: Disposable Income Per Capita, CNY, 2020; Source: The National Bureau of Statistics of China
Spatial price differences of medical services: evidence from the Yangtze River Delta in China

July 2023

·

20 Reads

·

4 Citations

BMC Health Services Research

Background Price differences of medical services across regions may affect equity in health financing. This study aimed to estimate the spatial price index of medical services to measure price levels across regions in the Yangtze River Delta, China. Methods Gini-Éltetö-Köves-Szulc method and minimum spanning tree method based on the purchasing power parities were used in this study. Results According to the Gini-Éltetö-Köves-Szulc method, Shanghai and Anhui province had price levels that are 127.55% and 103.45% respectively of the price level in Zhejiang province, whereas in Jiangsu medical services were priced at 92.71% of that in Zhejiang province. The spatial price index of medical services in the Yangtze River Delta based on the minimum spanning tree method provided similar results. Conclusions Regions in the Yangtze River Delta had significant gaps in medical services price levels. And the price levels tended to not correlate with socioeconomic levels. It is necessary to promote the regional coordination of medical services price and better achieve equity in health.

Citations (2)


... The initial phase systematically eliminated drug markups and established a dynamic adjustment system for medical service fees. The subsequent phase pioneered a zero markup policy of medical consumables and created a price linkage adjustment matrix of medical service items [17]. The experience accumulated by the pilot in Beijing has important policy diffusion value for deepening the reform of the medical supply side, and offers critical insights for assessing China's healthcare reform [18,19]. ...

Reference:

Did China’s hospital reforms improve curative care expenditures? Evidence from Beijing hospitals
Assessing the price levels of medical service and influential factors: evidence from China

BMC Public Health

... For instance, Yan et al. (2022) suggested that the direct reimbursement settlement policy within provinces significantly reduces catastrophic health expenditures for residents [37]. In contrast, Li et al. (2021) argued that the convenience of cross-provincial direct reimbursement policies in the Yangtze River Delta region has not resulted in a siphoning effect [38]. However, prior research has not framed the comparison of inter-city and inter-provincial direct reimbursements within a unified analytical framework. ...

Spatial price differences of medical services: evidence from the Yangtze River Delta in China

BMC Health Services Research